Hemab Therapeutics announces positive Phase 2 multiple ascending dose study results for sutacimig

Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA

Champions Oncology expands bioanalytical services with new technology and leadership

Mirum Pharmaceuticals to acquire Bluejay Therapeutics for HDV treatment

Poolbeg Pharma trial to feature in major CRS research programme

PureTech clears key FDA milestone for Phase 3 development of deupirfenidone

Proteome Sciences wins third US biopharma contract for new clinical assay

Lundbeck reports results from long-term follow-up of epilepsy patients treated with bexicaserin

CARsgen Therapeutics presents CT0596 study data at 2005 ASH Annual Meeting

AsymBio starts commercial production at Shanghai Fengxian Manufacturing Base

Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA

Hope Medicine wins FDA Fast Track Designation for HMI-115 in endometriosis

Bayer launches Phase IIa trial of BAY 3401016 for Alport Syndrome

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase